Variations among non-sedating antihistamines: Are there real differences?

European Journal of Clinical Pharmacology

Volumn 55, Issue 2, 1999, Pages 85-93

  Mattila, Mauri J ^a   Paakkari, Ilari ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; EBASTINE; FEXOFENADINE; LORATADINE; MIZOLASTINE; MUSCARINIC RECEPTOR BLOCKING AGENT; TERFENADINE;

ALLERGIC RHINITIS; CARDIOTOXICITY; DOSE RESPONSE; DRUG CLEARANCE; DRUG SAFETY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REVIEW; RHINITIS; SEDATION; SLEEP; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0032968275     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050600     Document Type: Review

References (72)

1. Smith SJ (1994) Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 111 (3 pt 2): 348-354
2. Monti JE (1993) Involvement of histamine in the control of the waking state. Life Sci 53: 1331-1338
3. 1-receptor activation reduces a background leakage potassium current. Neuroscience 59: 579-588.
4. Schwartz J-C, Aurang J-M, Garbarg M, Traiffort E. Histamine (1995) In Bloom FE & Kupfer DJ (eds) Psychopharmacology, the fourth generation of progress, pp. 397-405, Raven Press, New York
5. Mattila MJ, Mattila M, Konno K (1986) Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine. Eur J Clin Pharmacol 1986; 31: 291-298
6. 1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 104: 270-276
7. 1 antagonists measured by positron emission tomography. Br J Pharmacol 116: 1649-1655
8. Nicholson AN, Stone BM (1986) Antihistamines and performance. In de Gier JJ, O'Hanlon JF (eds) Drugs and driving, pp 283-289. Taylor & Francis, London
9. Levander S, Ståhle-Backdahl M, Hägermark Ö (1991) Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol 41: 435-439
10. 1-receptors. Life Sci 29: 547-552
11. 1-receptor antagonists. Eur J Clin Pharmacol 28: 523-529
12. Cohen AF, Posner J, Ashby L, Smith R, Peck AW (1984) A comparison of methods for assessing the sedative effects of diphenhydramine on skills related to car driving. Eur J Clin Pharmacol 27: 477-482
13. 2-receptors antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis. J Psychopharmacol 3: 125-129
14. Snyder SH, Snowman AM (1987) Receptor effects of cetirizine. Ann Allergy 56 (6 pt 2): 4-8
15. Warin RP (1984) The effects of large doses of H1-antagonist in urticaria. Br J Dermatol 111: 121
16. Hey JE, del Prado M, Sherwood J, Kreutner W, Egan RW (1996) Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model of adverse clinical ECG effects. Arzneim-Forsch/Drug Res 46 2, 1-8
17. Woosley RL (1996) Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 36: 233-252
18. O'Hanlon JF, Raemakers JG (1995) Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-1994. Allergy 50: 234-242
19. Monroe EW, Daly AF, Shalhoub RF (1997) Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines. J Allergy Clin Immunol 99: S798-S806
20. deShazo RD, Levinson AI, Dvorack HF, Davis RW (1979) The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol 122: 692-698
21. 1-receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 262: 964-970
22. Reunala T, Brummer-Korvenkontio H, Petman L, Palosuo T, Sarna S (1997) Effect of ebastine on mosquito bites. Acta Derm-Venereol 77: 315-316
23. Busse WW (1994) Role of antihistamines in allergic disease. Ann Allergy 72: 371-375
24. Cohen AF, Hamilton M, Philipson R, Peck A (1985) The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects. Clin Pharmacol Ther 38: 381-386
25. Brogden RN, McTavish D (1991) Acrivastine: a review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Drugs 41: 927-940
26. Leynadier F, Murrieta M, Dry J, Colin JN, Gillotin, Steru D (1994) Effects of acrivastine and terfenadine on skin reactivity to histamine. Ann Allergy 72: 520-524
27. Dollery C (ed). Therapeutic drugs, vol 1, pp A151-A153, Churchill Livingstone, Edinburgh, 1991
28. Seppälä T, Savolainen K (1982) Effect of astemizole on human psychomotor performance. Curr Ther Res 31: 638-644
29. 1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol 13: 199-202
30. 1-antihistamines. Clin Pharmacokinet 28: 419-432
31. Campoli-Richards DM, Buckley MM-T, Fitton A (1990) Cetirizine: a review of its pharmacological properties and potential in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs 40: 762-781
32. Spencer CM, Faulds D, Peters DH (1993) Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 46: 1055-1080
33. Seidel WF, Cohen S, Blivise NG, Dement WC (1990) Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standard electroencephalographic assessment. J Allergy Clin Immunol 86: 1029-1033
34. Pechadre JC, Beudin P, Eschalier A, Trolese JF, Rihoux J-P (1991) A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res 19: 289-295
35. Ramaekers JG, Uitervijk MMC, O Hanlon JF (1992) Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 42: 363-369
36. Patat A, Stubbs D, Dunmore C, Ulliac N, Sexton B, Zieleniuk I, Irving A, Jones W (1995) Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects. Eur J Clin Pharmacol 48: 143-150
37. Falliers CJ, Brandon ML, Buchman E, Connell JT, Dockhorn R, Leese PT, Miller J, Wasserman SI, Zeterberg JM, Altman R, Love S, Samuels LL (1991) Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 66: 257-262
38. Rosenzweig P, Caplain H, Chaufour S, Ulliac N, Cabanis MJ, Thebault JJ (1995) Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Br J Clin Pharmacol 40: 459-465
39. Meltzer EO, Weiler JM, Widlitz MD (1996) Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 97: 617-626
40. Wiseman LR, Faulds D (1996) Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 51: 260-277
41. Vincent J, Sumner DJ, Reid JL (1988) Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects. Br J Clin Pharmacol 26: 503-508
42. Mattila MJ, Kuitunen T, Pletan Y (1992) Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 43: 179-184
43. Haria M, Fitton A, Peters DH (1994) Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 48: 617-637
44. 1-antagonist, loratadine. Eur J Clin Pharmacol 32: 419-421
45. Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F (1987) Sedative effects of antihistamines. J Allergy Clin Immunol 80: 94-98
46. 1-antihistamine. Ann Allergy 69: 135-139
47. Bousquet J, Chanal I, Murrieta M, Stalla-Bourdillon A (1996) Lack of subsensitivity to mizolastine over 8-week treatment. Allergy 51: 251-256
48. Kerr JS, Dunmore C, Hindmarch (1994) The psychomotor and cognitive effects of mizolastine, compared to terfenadine 60 mg, triprolidine 10 mg and placebo in healthy volunteers. Eur J Clin Pharmacol 47: 331-335
49. Vuurman EF, Uitervijk MM, Rosenzweig P, O'Hanlon JF (1994) Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 47: 253-259
50. Patat A, Gram LF, Dubruc C, Brohier S, Cabanis MJ, Rosenzweig P (1994) Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Int Clin Psychopharmacol 9: 101-108
51. 1-antihistamine and erythromycin. Clin Pharmacol Ther 63: 214
52. Dollery C (ed) (1994) Therapeutic drugs, suppl 2, pp 248-253, Churchill Livingstone, Edinburgh
53. Labrecque M, Ghezzo H, L'Archevegue J, Trudeau C, Cartier A, Malo JL (1993) Duration of effect of loratadine and terfenadine administered once a day for one week on cutaneous and inhaled reactivity to histamine. Chest 103: 777-781
54. Lippert C, Ling J, Brown P, Burmeister S, Eller M, Cheng L, Thompson R, Weir S (1995) Mass balance and pharmacokinetics of fexofenadine HCl in healthy male volunteers. Pharm Res 12, suppl: F390
55. Markham A, Wagstaff AJ (1998). Fexofenadine. Drugs 55: 269-274
56. 1-blockade of fexofenadine. Ann Allergy Asthma Immunol 79: 530-532
57. Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt RA, Mason J (1997) Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 79: 443-448
58. Simons EFR, Bergman JN, Watson WTA, Simons K (1996) The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol 98: 1062-1064
59. 1-receptor antagonist, on histamine-induced skin wheals and the relationship to plasma drug concentrations in normal human volunteers. Br J Clin Pharmacol 35: 166-170
60. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB (1994) Interheterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab Dispos 22: 947-955
61. Vanganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vinken W (1997) Effects of antihistamines in adult asthma - a meta-analysis of clinical trials. Eur Resp J 10: 2216-2224
62. R. Pediatr Allergy Immunol 9: 116-124
63. Day JH, Briscoe MP, Clark RH, Ellis AK, Gervais P (1997) Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 79: 163-172
64. Spaeth J, Klimek L, Mosges R (1996) Sedation of allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 51: 893-906
65. Krause LB, Shuster S (1983) Mechanism of action of antipruritic drugs. Br Med J 287: 1199-1200
66. 1-antihistamines in chronic urticaria. Ann Allergy 71: 585-591
67. Maibach HI, Wahlgren C-F (eds) (1995) Pruritus. Seminars in dermatology, Vol 14 (December) W.B. Saunders Company, Philadelphia
68. Adelsberg BR (1991) Sedation and performance issues in the treatment of allergic conditions. Arch Int Med 157: 494-500
69. Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK (1995) Risk of selected serious cardiac events among new users of antihistamines. Clin Ther 17: 1062-1077
70. c interval: impact on defining drug effect and low-frequency cardiac event. Am J Cardiol 72: 26B-31B
71. Lindquist M, Edwards IR (1997) Risks of non-sedating antihistamines. Lancet 349: 1322
72. Rankin AC (1997) Non-sedating antihistamines and cardiac arrhythmia. Lancet 350: 1115-1116